TrialJournal of diabetes investigation2020

Dulaglutide-combined basal plus correction insulin therapy contributes to ideal glycemic control in non-critical hospitalized patients.

Nobutoshi Fushimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.